» Articles » PMID: 17030227

Clinical and Pathologic Perspectives on Aspirin Sensitivity and Asthma

Overview
Date 2006 Oct 13
PMID 17030227
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Aspirin and other nonsteroidal anti-inflammatory drugs that inhibit COX-1 induce unique nonallergic reactions, consisting of attacks of rhinitis and asthma. These hypersensitivity reactions occur in a subset of asthmatic subjects, thus identifying them as having this exclusive clinical presentation. We refer to these patients as having aspirin-exacerbated respiratory disease, a disease process that produces devastating eosinophilic inflammation of both the upper and lower respiratory tracts. This review focuses on a description of patients with aspirin-exacerbated respiratory disease, methods available to diagnose their condition, the unique ability of all nonsteroidal anti-inflammatory drugs that inhibit COX-1 to cross-react with aspirin, an update on pathogenesis, and current thoughts about treatment.

Citing Articles

Hypersensitivity to intravenous succinate corticosteroids in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease.

Taniguchi M, Sato A, Mita H Front Allergy. 2023; 4:1145809.

PMID: 38026126 PMC: 10667677. DOI: 10.3389/falgy.2023.1145809.


The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).

Cousins K, Chen C, Sehanobish E, Jerschow E Adv Pharmacol. 2023; 97:423-444.

PMID: 37236766 PMC: 10591515. DOI: 10.1016/bs.apha.2022.12.002.


Nonsteroidal anti-inflammatory drugs exacerbated respiratory disease - the role of aspirin desensitisation in patients with nasal polyposis.

Jenerowicz D, Szyfter-Harris J, Mietkiewska-Leszniewska D, Czarnecka-Operacz M, Wierzbicka M, Adamski Z Postepy Dermatol Alergol. 2022; 39(3):617-619.

PMID: 35950106 PMC: 9326928. DOI: 10.5114/ada.2021.103305.


Baseline Conservative and Surgical Management in the Treatment of NSAID-Exacerbated Respiratory Disease.

Sillanpaa S, Numminen J Front Allergy. 2022; 2:659887.

PMID: 35387049 PMC: 8974786. DOI: 10.3389/falgy.2021.659887.


Pathomechanisms of AERD-Recent Advances.

Lyly A, Laidlaw T, Lundberg M Front Allergy. 2022; 2:734733.

PMID: 35387030 PMC: 8974777. DOI: 10.3389/falgy.2021.734733.